MetLife director granted 1,016 deferred shares
HUBBARD ROBERT GLENN reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
HUBBARD ROBERT GLENN reported acquisition or exercise transactions in this Form 4 filing.
MetLife Inc. director Robert Glenn Hubbard received an equity grant of 1,016 shares of common stock, valued at $87.40 per share, as part of non-management director retainer compensation. He elected to defer receipt of these shares under MetLife’s Deferred Compensation Plan for Non-Management Directors, and now holds 107,573 common shares directly after this award.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 1,016 | $87.40 | $89K |
Footnotes (1)
- F1. MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees and Board Chair retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.
Key Figures
Key Terms
non-management director retainer fees financial
Deferred Compensation Plan for Non-Management Directors financial
common stock financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did MetLife (MET) director Robert Glenn Hubbard report?
Was Robert Glenn Hubbard’s MetLife (MET) transaction a market buy or a compensation award?
AI-generated analysis. How Rhea-AI works. Not financial advice.